Company: IPHYF
Filing Date: 2025-04-30
Form Type: 20-F
Source: 0001598599-25-000042
Chunk: 366

Company: Innate Pharma SA
Filing Date: 2025-04-30
Form: 20-F
Item: Item 19
Chunk 366
---
), Jonathan Dickinson, and two two

F-87

Dickinson would remain Chairman and Yannis Morel and Sonia Quaratino would remain members (Arvind Sood resigned from his position on the Executive Board in February 2025).

• On April 23, 2025, the Company announced review of their January 2016 Research Collaboration and License Agreement (the “2016 Agreement”) with Sanofi:

◦ as previously disclosed and in alignment with its current strategic priorities, Sanofi will opt to pursue the development of SAR’514/IPH6401 (BCMA ANKET®) in autoimmune indications;

◦ in alignment with both company's current strategic priorities, Sanofi and Innate agreed to terminate the 2016 Agreement as it relates to SAR’579/IPH6101 (CD123 ANKET); Innate will regain its rights on SAR’579/IPH6101 (CD123 ANKET);

◦ as part of these discussions, Sanofi and Innate agreed to a potential investment by Sanofi of up to € 15,000,000

◦ On April 24, 2025, the Company announced that, given the satisfactory market conditions, Sanofi has agreed to subscribe to 8,345,387 1.7974 14,999,998.59 417,269.35 14,582,729.24 of issue premium). As a result, the Company’s share capital was increased to € 4,609,489.90 92,175,723 6,494 7,581The tables below set out the Company’s shareholding, based on the information available to Innate as of the date of this report, before and after the closing of the capital increase:

Before closing

  Shareholder                                                                Nb of Shares [1]            %      Nb of voting rights [2]            %  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Novo Nordisk A/S                                                                  9,817,546       11.71%                    9,817,546       11.60%  
  Medimmune Limited                                                                 7,485,500        8.93%                    7,485,500        8.85%  
  Bpifrance Participations                                                          6,389,406        7.62%                    6,389,406        7.55%  
  Members